Anlon Healthcare, a smallcap pharmaceutical company, is set to implement a 1:1 bonus issue and a 1:5 stock split, with the record date scheduled for April 24. Today marks the last opportunity for investors to buy shares to qualify for these corporate actions, which aim to increase liquidity and affordability. Under the stock split, each share with a face value of ₹10 will be divided into five shares with a face value of ₹5. Additionally, eligible shareholders will receive one bonus share for each share held as of the record date. Anlon Healthcare made its market debut in September 2022 at ₹92 per share, slightly above its IPO price of ₹91, and has experienced fluctuations in its share price, peaking at ₹172.75 in November 2025. Currently, the stock is trading at ₹149.4, still over 62% higher than its initial listing price.